These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pretreatment with deaggregated horse gamma-globulin. Failure to enhance tolerance to horse antilymphoblast globulin in man. Moberg AW; Gewurz H; Simmons RL; Najarian JS Transplantation; 1970 Oct; 10(4):344-6. PubMed ID: 4101178 [No Abstract] [Full Text] [Related]
24. [Antilymphocyte serum: choice of antigen for its preparation and immunosuppression tests]. Traeger J; Fries D; Perrin J; Saubier E; Revillard JP; Brochier J; Dubernard JM; Carraz M; Plan M; Archimbaud JP J Urol Nephrol (Paris); 1969 Sep; 75(9):584-9. PubMed ID: 4997175 [No Abstract] [Full Text] [Related]
25. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Kashiwagi N; Brantigan CO; Brettschneider L; Groth CG; Starzl TE Ann Intern Med; 1968 Feb; 68(2):275-86. PubMed ID: 4181614 [TBL] [Abstract][Full Text] [Related]
26. [Anti-thymocyte globulin for immunosuppression]. Collste LG; Franksson C; Groth CG; Jacobson S; Magnusson G; Schantz B; Svehag SE; Werner B Nord Med; 1971; 86(46):1358. PubMed ID: 4944024 [No Abstract] [Full Text] [Related]
30. Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum. Sell K; Woody J; Smith J; Darrow C; Kayhoe D Transplant Proc; 1973 Mar; 5(1):541-7. PubMed ID: 4633091 [No Abstract] [Full Text] [Related]
31. [Immunosuppression in organ transplantation (author's transl)]. Montandon A Ther Umsch; 1979 May; 36(5):418-25. PubMed ID: 88084 [No Abstract] [Full Text] [Related]
32. The preparation and testing of antihuman lymphoblast globulin for clinical use. Phillips AW; Woodrooffe JG; Courtenay JS; Whitaker AM; Thomas D; Woiwod AJ Transplantation; 1976 Aug; 22(2):167-75. PubMed ID: 823671 [TBL] [Abstract][Full Text] [Related]
35. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. I. Preparation of antilymphocyte serum. Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH Laryngoscope; 1972 Jan; 82(1):61-73. PubMed ID: 4109440 [No Abstract] [Full Text] [Related]
36. The ocular immune response. II. Immune rejection of penetrating corneal homografts. Early versus late treatment with antilymphocyte serum. Waltman SR; Burde RM; Faulkner HW Transplantation; 1969 Aug; 8(2):147-51. PubMed ID: 4896328 [No Abstract] [Full Text] [Related]
37. [Problems in transplantation immunology]. Gabl F; Riethmüller G; Schumacher K; Zeiss I Z Immunitatsforsch Allerg Klin Immunol; 1967 Oct; 133(5):413-55. PubMed ID: 4233452 [No Abstract] [Full Text] [Related]
38. Human antilymphocyte serum. 2. Further preparations and in vivo testing. Sutherland SK; Morris PJ; Broad AJ Med J Aust; 1970 Feb; 1(8):362-6. PubMed ID: 4392443 [No Abstract] [Full Text] [Related]
39. The localization of the immunosuppressive activity in horse antimonkey lymphocyte sera. Betel I; Appelman AW; Balner H Transplantation; 1970 Apr; 9(4):431-6. PubMed ID: 4101176 [No Abstract] [Full Text] [Related]
40. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Najarian JS; Simmons RL; Condie RM; Thompson EJ; Fryd DS; Howard RJ; Matas AJ; Sutherland DE; Ferguson RM; Schmidtke JR Ann Surg; 1976 Sep; 184(3):352-68. PubMed ID: 786192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]